Business Standard
Thursday, May 31, 2012
     
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
|||Banking & Finance|||||| 
 Section Home | News Now | Today's Paper | Columnists | BS Says | Money & Forex Markets | Q&A | Bank | Insurance | Monetary Policy | Banking Annual
Home > Banking & Finance Live Markets | Commodities
 

No more loans against Ulips
Plans with loan clause denied approval regulatory ban coming
Manojit Saha & Niladri Bhattacharya / Mumbai Jan 26, 2012, 00:14 IST

The Insurance Regulatory and Development Authority (Irda) plans to ban loans by life insurance companies against unit-linked life insurance policies (Ulips). The insurance regulator is not approving any unit-linked plans with a clause of loans against policy.

“Irda has rejected our new unit-linked plan and has asked us to refile it after removing the loan facility clause,” said a senior official at a large private life insurance company on the condition of anonymity.

Confirming the development, Irda Chairman J Hari Narayan said, “Fundamentally, Ulips are risky products, given that they are linked with the stock market. In case the fund value drops dramatically due to negative price movement, the risk would come to the insurers. Hence, loans against such products are not advisable.”

Insurance officials said the move might further dent the sales of Ulips as the loan facility acted as an added feature. The facility first came into force after Irda raised the lock-in period for such plans by two years to five in September 2010.

LOANS AGAINST MARKET-LINKED PLANS RISKY
* Irda not approving any Ulips with loan facility
* Sept 2010  Loans against Ulips started
* 75% of the fund value could be the maximum loan amount 
* Interest rate offered was benchmarked against the base rate of banks —  currently around 10.75-11% 
* Highest loan tenure could equal the policy tenure 
* 90% of the fund value can be the maximum loan amount for traditional policies

“The loan facility was one of the selling points for these long-term insurance products. So, this would impact the sales of unit-linked plans,” said K Sahay, CEO, Star Union Dai-ichi Life.

Earlier, when the lock-in period was three years, policyholders were allowed part-withdrawal after the period. With a lock-in period of five years, the loan facility was provided to meet customers' short-term fund requirements, said an official of a private life insurance company.

Another reason behind allowing loans was to prevent policyholders in need of short-term funds from surrendering the policy, added an actuary at a private life insurance company.

The loan amount against a unit-linked policy depends on the extent of the equity exposure in the portfolio. Generally, insurance companies provide up to 70-75 per cent of the fund value of a unit-linked policy as loan if more than 60 per cent of the fund is invested in debt instruments. However, the loan amount comes down to 50 per cent of the fund value where equity exposure accounts for more than 60 per cent of the total portfolio.

For traditional or endowment plans, companies extend loans up to 90 per cent of the fund value. The rate of interest varies from 9.5-12 per cent per annum, benchmarked against the base rates of public sector banks. The loan tenure can be as high as the policy term. "Traditional or endowment plans are safer products and we have no issues with a loan facility against these plans," the Irda chairman added.

Since September 2010, when stringent unit-linked guidelines came into force, insurance companies have focused more on traditional plans and the sale of Ulips, which till then constituted 80 per cent of the total volume, came down drastically. In the current financial year, the downward trend has continued, with a choppy equity market and high inflation adding to the problems. During April-November, premium collection by the life insurance industry was down almost 19 per cent to Rs 2,428.86 crore from Rs 76,989.88 crore reported in the year-ago period. Ulips accounted for only 20-25 per cent of the sales.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end lower ahead of May F&O expiry
- Parsvnath posts Rs 23 cr loss in Q4
- Educomp net down 57% at Rs 61 cr in Jan-Mar qtr
- DLF Q4 net plunges 39% to Rs 211 cr
- Provogue Q4 net profit down 71% at Rs 1.81 cr
  Read Business news in 
- India's no. 1 Property Site. Click here to know more
- 
- Help a Child Achieve her. Click to know more
- Watch The Film Here. Click here to know more..
- Learn How One City is Running on FOOD SCRAPS.
- 1 billion in saving for Unilever without any tangles.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
- 2 Lac Apartments, 1 Lac House / Plots. Click here
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Vodafone notice on arbitration premature: Govt
- Dissidence brewing in state: Senior BJP leaders team up against Modi
- Tata Motors skids as margins dip at JLR
- Coal blocks for infrastructure projects get GoM nod
- GSFC to augment capacities with Rs 800 cr investment
 
 More  
Tax Shastra
  Now available at Special price
  Rs. 360/- Only

  Buy Now
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us